Naquotinib | m-entrepreneurship.com

Product Name :
Naquotinib

Search keywords :
Naquotinib (mesylate)

drugId :
null

Target Vo:
EGFR T790M

Target Vo Short Name :
EGFR T790M

Moa_Name:
EGFR T790M inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Astellas Pharma Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :
Phase 3 Clinical

China Termination Status :
IND

Highest Status:
Discontinued

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bedinvetmab Autophagy
Dnmt1 Rabbit mAb Purity & Documentation
BMAL1 Antibody: BMAL1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to BMAL1. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts